This company listing is no longer active
ALPHS Stock Overview
Pharmasimple SA operates a Website for medicines, cosmetics, and food supplements in Belgium and France. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Pharmasimple SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.013 |
| 52 Week High | €2.70 |
| 52 Week Low | €0.011 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -98.91% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Shareholder Returns
| ALPHS | FR Specialty Retail | FR Market | |
|---|---|---|---|
| 7D | 0% | 3.3% | 2.7% |
| 1Y | -98.9% | 8.8% | 3.5% |
Return vs Industry: ALPHS underperformed the French Specialty Retail industry which returned -30.2% over the past year.
Return vs Market: ALPHS underperformed the French Market which returned 3.5% over the past year.
Price Volatility
| ALPHS volatility | |
|---|---|
| ALPHS Average Weekly Movement | 0% |
| Specialty Retail Industry Average Movement | 5.1% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 10.2% |
| 10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: ALPHS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ALPHS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Michael Willems | www.pharmasimple.com |
Pharmasimple SA operates a Website for medicines, cosmetics, and food supplements in Belgium and France. It offers face products comprising accessories, creams, cleansers, scrubs, masks, supplements, tanners, and other care products; body and hair, makeup, solar, and products; waters and perfumes; food supplements; health accessories, bandages, devices, first-aid, and pain/ache, as well as diet products; and masks, thermometers, glover, air purifiers, and home and hand hygiene products. The company also provides toilet, and mom and baby care; sliming and sports products; daily, oral, and organic hygiene products; and aromatherapy, bach flowers, homeopathy, apitherapy, herbalism, phytotherapy, gemmotherapy, floral elixirs, balneotherapy, light therapy, lithotherapy, and magnetotherapy medicines; as well as male, animals, and organic and natural products.
Pharmasimple SA Fundamentals Summary
| ALPHS fundamental statistics | |
|---|---|
| Market cap | €124.51k |
| Earnings (TTM) | -€4.79m |
| Revenue (TTM) | €31.93m |
0.0x
P/S Ratio0.0x
P/E RatioIs ALPHS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALPHS income statement (TTM) | |
|---|---|
| Revenue | €31.93m |
| Cost of Revenue | €34.35m |
| Gross Profit | -€2.42m |
| Other Expenses | €2.37m |
| Earnings | -€4.79m |
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ALPHS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/09 10:09 |
| End of Day Share Price | 2024/02/09 00:00 |
| Earnings | 2021/06/30 |
| Annual Earnings | 2020/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pharmasimple SA is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Florent Thy-Tine | TPICAP Midcap |